These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12606226)

  • 1. The benefits of ribose in cardiovascular disease.
    Pauly DF; Johnson C; St Cyr JA
    Med Hypotheses; 2003 Feb; 60(2):149-51. PubMed ID: 12606226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patented uses of D-ribose in cardiovascular diseases.
    Shecterle LM; Terry KR; St Cyr JA
    Recent Pat Cardiovasc Drug Discov; 2010 Jun; 5(2):138-42. PubMed ID: 20236088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribose in the heart.
    Herrick J; St Cyr J
    J Diet Suppl; 2008; 5(2):213-7. PubMed ID: 22432434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease.
    Shecterle LM; Terry KR; St Cyr JA
    Cureus; 2018 Mar; 10(3):e2291. PubMed ID: 29750132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-ribose aids advanced ischemic heart failure patients.
    MacCarter D; Vijay N; Washam M; Shecterle L; Sierminski H; St Cyr JA
    Int J Cardiol; 2009 Sep; 137(1):79-80. PubMed ID: 18674831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model.
    St Cyr JA; Bianco RW; Schneider JR; Mahoney JR; Tveter K; Einzig S; Foker JE
    J Surg Res; 1989 Feb; 46(2):157-62. PubMed ID: 2493108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preischemic administration of ribose to delay the onset of irreversible ischemic injury and improve function: studies in normal and hypertrophied hearts.
    Wallen WJ; Belanger MP; Wittnich C
    Can J Physiol Pharmacol; 2003 Jan; 81(1):40-7. PubMed ID: 12665256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ribose, adenosine, and "AICAR" on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog.
    Mauser M; Hoffmeister HM; Nienaber C; Schaper W
    Circ Res; 1985 Feb; 56(2):220-30. PubMed ID: 3918804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic derangement in ischemic heart disease and its therapeutic control.
    Ferrari R; Pepi P; Ferrari F; Nesta F; Benigno M; Visioli O
    Am J Cardiol; 1998 Sep; 82(5A):2K-13K. PubMed ID: 9737480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribose-enhanced myocardial recovery following ischemia in the isolated working rat heart.
    Pasque MK; Spray TL; Pellom GL; Van Trigt P; Peyton RB; Currie WD; Wechsler AS
    J Thorac Cardiovasc Surg; 1982 Mar; 83(3):390-8. PubMed ID: 6174831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted metabolic protocol with D-ribose for off-pump coronary artery bypass procedures: a retrospective analysis.
    Perkowski DJ; Wagner S; Schneider JR; St Cyr JA
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):185-92. PubMed ID: 21693564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sugar for congestive heart failure patients.
    Shecterle LM; Wagner S; St Cyr JA
    Ther Adv Cardiovasc Dis; 2011 Apr; 5(2):95-7. PubMed ID: 21310762
    [No Abstract]   [Full Text] [Related]  

  • 14. D-ribose, a metabolic substrate for congestive heart failure.
    Wagner S; Herrick J; Shecterle LM; St Cyr JA
    Prog Cardiovasc Nurs; 2009 Jun; 24(2):59-60. PubMed ID: 19523159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of different carbohydrates as substrates for the isolated working heart.
    Mahoney JR; Sako EY; Seymour KM; Marquardt CA; Foker JE
    J Surg Res; 1989 Dec; 47(6):530-4. PubMed ID: 2511381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-ribose benefits "off" pump coronary artery bypass revascularization.
    Perkowski D; Wagner S; St Cyr JA
    J Card Surg; 2007; 22(4):370-1. PubMed ID: 17661790
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial ischemia and reperfusion reduce the levels of cyclic ADP-ribose in rat myocardium.
    Ge ZD; Li PL; Chen YF; Gross GJ; Zou AP
    Basic Res Cardiol; 2002 Jul; 97(4):312-9. PubMed ID: 12111041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion.
    Haas GS; DeBoer LW; O'Keefe DD; Bodenhamer RM; Geffin GA; Drop LJ; Teplick RS; Daggett WM
    Circulation; 1984 Sep; 70(3 Pt 2):I65-74. PubMed ID: 6430593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.